This site is for US healthcare professionals to provide online access to current, accurate, scientific information about our products. It is prepared by Janssen Medical Information and is not intended for promotional purposes, nor for medical advice.

  1. Home
  2. Announcements
  3. Selected Announcement

ERLEADA® (apalutamide) FDA Approval of Supplemental New Drug Application (sNDA) Press Release

ERLEADA® (apalutamide) FDA Approval of Supplemental New Drug Application (sNDA) Press Release.